Loading...
Header Logo
Keywords
Last Name
Institution

GEORGE STANCEL

TitleProfessor
InstitutionMD Anderson
DepartmentGynecological Oncology & Reproductive Medicine
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Yang F, Li W, Jiang N, Yu H, Morohashi K, Ouma WZ, Morales-Mantilla DE, Gomez-Cano FA, Mukundi E, Prada-Salcedo LD, Velazquez RA, Valentin J, Mejía-Guerra MK, Gray J, Doseff AI, Grotewold E. A Maize Gene Regulatory Network for Phenolic Metabolism. Mol Plant. 2017 03 06; 10(3):498-515. PMID: 8441856.
      View in: PubMed
    2. Deng L, Broaddus RR, McCampbell A, Shipley GL, Loose DS, Stancel GM, Pickar JH, Davies PJ. Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer. Clin Cancer Res. 2005 Dec 01; 11(23):8258-64. PMID: 16322283.
      View in: PubMed
    3. Liang Y, Wu J, Stancel GM, Hyder SM. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells. J Steroid Biochem Mol Biol. 2005 Feb; 93(2-5):173-82. PMID: 15860260.
      View in: PubMed
    4. Deng L, Shipley GL, Loose-Mitchell DS, Stancel GM, Broaddus R, Pickar JH, Davies PJ. Coordinate regulation of the production and signaling of retinoic acid by estrogen in the human endometrium. J Clin Endocrinol Metab. 2003 May; 88(5):2157-63. PMID: 12727970.
      View in: PubMed
    5. Hyder SM, Stancel GM. Inhibition of progesterone-induced VEGF production in human breast cancer cells by the pure antiestrogen ICI 182,780. Cancer Lett. 2002 Jul 08; 181(1):47-53. PMID: 12430178.
      View in: PubMed
    6. Melnick R, Lucier G, Wolfe M, Hall R, Stancel G, Prins G, Gallo M, Reuhl K, Ho SM, Brown T, Moore J, Leakey J, Haseman J, Kohn M. Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. Environ Health Perspect. 2002 Apr; 110(4):427-31. PMID: 11940462.
      View in: PubMed
    7. Hyder SM, Chiappetta C, Stancel GM. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells. Int J Cancer. 2001 May 15; 92(4):469-73. PMID: 11304678.
      View in: PubMed
    8. Hyder SM, Huang JC, Nawaz Z, Boettger-Tong H, Mäkelä S, Chiappetta C, Stancel GM. Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environ Health Perspect. 2000 Oct; 108 Suppl 5:785-90. PMID: 11035983.
      View in: PubMed
    9. Hyder SM, Chiappetta C, Stancel GM. Induction of the angiogenic factor VEGF in the uterus by the antiprogestin onapristone. Cancer Lett. 2000 Aug 01; 156(1):101-7. PMID: 10840165.
      View in: PubMed
    10. Hyder SM, Nawaz Z, Chiappetta C, Stancel GM. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res. 2000 Jun 15; 60(12):3183-90. PMID: 10866309.
      View in: PubMed
    11. Hyder SM, Stancel GM. Regulation of VEGF in the reproductive tract by sex-steroid hormones. Histol Histopathol. 2000 01; 15(1):325-34. PMID: 10668221.
      View in: PubMed
    12. Dickson RB, Stancel GM. Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr. 2000; (27):135-45. PMID: 10963625.
      View in: PubMed
    13. Ben-Jonathan N, Cooper RL, Foster P, Hughes CL, Hoyer PB, Klotz D, Kohn M, Lamb DJ, Stancel GM. An approach to the development of quantitative models to assess the effects of exposure to environmentally relevant levels of endocrine disruptors on homeostasis in adults. Environ Health Perspect. 1999 Aug; 107 Suppl 4:605-11. PMID: 10421770.
      View in: PubMed
    14. Hyder SM, Chiappetta C, Stancel GM. Synthetic estrogen 17alpha-ethinyl estradiol induces pattern of uterine gene expression similar to endogenous estrogen 17beta-estradiol. J Pharmacol Exp Ther. 1999 Aug; 290(2):740-7. PMID: 10411586.
      View in: PubMed
    15. Hyder SM, Stancel GM. Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins. Mol Endocrinol. 1999 Jun; 13(6):806-11. PMID: 10379879.
      View in: PubMed
    16. Hyder SM, Chiappetta C, Stancel GM. Interaction of human estrogen receptors alpha and beta with the same naturally occurring estrogen response elements. Biochem Pharmacol. 1999 Mar 15; 57(6):597-601. PMID: 10037443.
      View in: PubMed
    17. Nawaz Z, Stancel GM, Hyder SM. The pure antiestrogen ICI 182,780 inhibits progestin-induced transcription. Cancer Res. 1999 Jan 15; 59(2):372-6. PMID: 9927049.
      View in: PubMed
    18. Boettger-Tong H, Murthy L, Chiappetta C, Kirkland JL, Goodwin B, Adlercreutz H, Stancel GM, Mäkelä S. A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens. Environ Health Perspect. 1998 Jul; 106(7):369-73. PMID: 9637793.
      View in: PubMed
    19. Hyder SM, Chiappetta C, Stancel GM. The 3-flanking region of the mouse c-fos gene contains a cluster of GGTCA hormone response-like elements. Mol Biol Rep. 1998 Jul; 25(3):189-91. PMID: 9700055.
      View in: PubMed
    20. Kirkland JL, Murthy L, Thomazy V, Hyder SM, Stancel GM. Phorbol ester inhibition of estrogen-induced uterine deoxyribonucleic acid synthesis. Biol Reprod. 1998 Mar; 58(3):778-85. PMID: 9510966.
      View in: PubMed
    21. Hyder SM, Murthy L, Stancel GM. Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer Res. 1998 Feb 01; 58(3):392-5. PMID: 9458078.
      View in: PubMed
    22. Hyder SM, Chiappetta C, Stancel GM. Triphenylethylene antiestrogens induce uterine vascular endothelial growth factor expression via their partial estrogen agonist activity. Cancer Lett. 1997 Dec 09; 120(2):165-71. PMID: 9461033.
      View in: PubMed
    23. Hyder SM, Chiappetta C, Murthy L, Stancel GM. Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780. Cancer Res. 1997 Jul 01; 57(13):2547-9. PMID: 9205050.
      View in: PubMed
    24. Boettger-Tong H, Shipley G, Hsu CJ, Stancel GM. Cultured human uterine smooth muscle cells are retinoid responsive. Proc Soc Exp Biol Med. 1997 May; 215(1):59-65. PMID: 9142138.
      View in: PubMed
    25. Salo LK, Mäkelä SI, Stancel GM, Santti RS. Neonatal exposure to diethylstilbestrol permanently alters the basal and 17 beta-estradiol induced expression of c-fos proto-oncogene in mouse urethroprostatic complex. Mol Cell Endocrinol. 1997 Feb 07; 126(2):133-41. PMID: 9089651.
      View in: PubMed
    26. Hyder SM, Stancel GM, Chiappetta C, Murthy L, Boettger-Tong HL, Makela S. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen. Cancer Res. 1996 Sep 01; 56(17):3954-60. PMID: 8752163.
      View in: PubMed
    27. Boettger-Tong HL, Murthy L, Stancel GM. Cellular pattern of c-fos induction by estradiol in the immature rat uterus. Biol Reprod. 1995 Dec; 53(6):1398-406. PMID: 8562697.
      View in: PubMed
    28. Stancel GM, Boettger-Tong HL, Chiappetta C, Hyder SM, Kirkland JL, Murthy L, Loose-Mitchell DS. Toxicity of endogenous and environmental estrogens: what is the role of elemental interactions? Environ Health Perspect. 1995 Oct; 103 Suppl 7:29-33. PMID: 8593870.
      View in: PubMed
    29. Boettger-Tong HL, Stancel GM. Retinoic acid inhibits estrogen-induced uterine stromal and myometrial cell proliferation. Endocrinology. 1995 Jul; 136(7):2975-83. PMID: 7789323.
      View in: PubMed
    30. Hyder SM, Shipley GL, Stancel GM. Estrogen action in target cells: selective requirements for activation of different hormone response elements. Mol Cell Endocrinol. 1995 Jul; 112(1):35-43. PMID: 7589783.
      View in: PubMed
    31. Hyder SM, Nawaz Z, Chiappetta C, Yokoyama K, Stancel GM. The protooncogene c-jun contains an unusual estrogen-inducible enhancer within the coding sequence. J Biol Chem. 1995 Apr 14; 270(15):8506-13. PMID: 7721748.
      View in: PubMed
    32. Kirkland J, Thomazy V, Murthy L, Stancel G. Phorbol esters inhibit estrogen-induced uterine DNA synthesis and increase apoptosis in uterine epithelium. Recent Prog Horm Res. 1995; 50:455-8. PMID: 7740181.
      View in: PubMed
    33. Hyder SM, Stancel GM, Loose-Mitchell DS. Steroid hormone-induced expression of oncogene encoded nuclear proteins. Crit Rev Eukaryot Gene Expr. 1994; 4(1):55-116. PMID: 7987047.
      View in: PubMed
    34. Hyder SM, Stancel GM. In vitro interaction of uterine estrogen receptor with the estrogen response element present in the 3'-flanking region of the murine c-fos protooncogene. J Steroid Biochem Mol Biol. 1994 Jan; 48(1):69-79. PMID: 8136308.
      View in: PubMed
    35. Kirkland JL, Murthy L, Stancel GM. Tamoxifen stimulates expression of the c-fos proto-oncogene in rodent uterus. Mol Pharmacol. 1993 May; 43(5):709-14. PMID: 8502228.
      View in: PubMed
    36. Stancel GM, Baker VV, Hyder SM, Kirkland JL, Loose-Mitchell DS. Oncogenes and uterine function. Oxf Rev Reprod Biol. 1993; 15:1-42. PMID: 8336974.
      View in: PubMed
    37. Nawaz Z, Stancel GM, McDonnell DP, Hyder SM. Creation of an active estrogen-responsive element by a single base change in the flanking sequence of a cellular oncogene: a possible mechanism for hormonal carcinogenesis? Mol Carcinog. 1993; 7(2):76-82. PMID: 8457291.
      View in: PubMed
    38. Hyder SM, Stancel GM, Nawaz Z, McDonnell DP, Loose-Mitchell DS. Identification of an estrogen response element in the 3'-flanking region of the murine c-fos protooncogene. J Biol Chem. 1992 Sep 05; 267(25):18047-54. PMID: 1517237.
      View in: PubMed
    39. Kirkland JL, Murthy L, Stancel GM. Progesterone inhibits the estrogen-induced expression of c-fos messenger ribonucleic acid in the uterus. Endocrinology. 1992 Jun; 130(6):3223-30. PMID: 1375896.
      View in: PubMed
    40. Liehr JG, Chiappetta C, Roy D, Stancel GM. Elevation of protooncogene messenger RNAs in estrogen-induced kidney tumors in the hamster. Carcinogenesis. 1992 Apr; 13(4):601-4. PMID: 1576713.
      View in: PubMed
    41. Chiappetta C, Kirkland JL, Loose-Mitchell DS, Murthy L, Stancel GM. Estrogen regulates expression of the jun family of protooncogenes in the uterus. J Steroid Biochem Mol Biol. 1992 Feb; 41(2):113-23. PMID: 1543678.
      View in: PubMed
    42. Hyder SM, Stancel GM, Loose-Mitchell DS. Presence of an estradiol response region in the mouse c-fos oncogene. Steroids. 1991 Oct; 56(10):498-504. PMID: 1805451.
      View in: PubMed
    43. Stancel GM, Chiapetta C, Gardner RM, Kirkland JL, Lin TH, Lingham RB, Loose-Mitchell DS, Mukku VR, Orengo CA. Regulation of the uterine epidermal growth factor receptor by estrogen. Prog Clin Biol Res. 1990; 322:213-26. PMID: 2406734.
      View in: PubMed
    44. Gardner RM, Stancel GM. Blockade of epidermal growth factor-induced uterine contractions by indomethacin or nordihydroguaritic acid. J Pharmacol Exp Ther. 1989 Sep; 250(3):882-6. PMID: 2506336.
      View in: PubMed
    45. Gardner RM, Verner G, Kirkland JL, Stancel GM. Regulation of uterine epidermal growth factor (EGF) receptors by estrogen in the mature rat and during the estrous cycle. J Steroid Biochem. 1989 Mar; 32(3):339-43. PMID: 2784840.
      View in: PubMed
    46. Loose-Mitchell DS, Chiappetta C, Stancel GM. Estrogen regulation of c-fos messenger ribonucleic acid. Mol Endocrinol. 1988 Oct; 2(10):946-51. PMID: 3141795.
      View in: PubMed
    47. Lin TH, Kirkland JL, Mukku VR, Stancel GM. Regulation of deoxyribonucleic acid polymerase activity in uterine luminal epithelium after multiple doses of estrogen. Endocrinology. 1988 Apr; 122(4):1403-9. PMID: 3126037.
      View in: PubMed
    48. Lin TH, Mukku VR, Verner G, Kirkland JL, Stancel GM. Autoradiographic localization of epidermal growth factor receptors to all major uterine cell types. Biol Reprod. 1988 Mar; 38(2):403-11. PMID: 3258762.
      View in: PubMed
    49. Lingham RB, Stancel GM, Loose-Mitchell DS. Estrogen regulation of epidermal growth factor receptor messenger ribonucleic acid. Mol Endocrinol. 1988 Mar; 2(3):230-5. PMID: 3398852.
      View in: PubMed
    50. Gardner RM, Lingham RB, Stancel GM. Contractions of the isolated uterus stimulated by epidermal growth factor. FASEB J. 1987 Sep; 1(3):224-8. PMID: 3497834.
      View in: PubMed
    51. Stancel GM, Gardner RM, Kirkland JL, Lin TH, Lingham RB, Loose-Mitchell DS, Mukku VR, Orengo CA, Verner G. Interactions between estrogen and EGF in uterine growth and function. Adv Exp Med Biol. 1987; 230:99-118. PMID: 3454125.
      View in: PubMed
    52. Liehr JG, Stancel GM, Chorich LP, Bousfield GR, Ulubelen AA. Hormonal carcinogenesis: separation of estrogenicity from carcinogenicity. Chem Biol Interact. 1986 Sep; 59(2):173-84. PMID: 3769051.
      View in: PubMed
    53. McMurtrie EM, Ginsberg GG, Frederick GT, Kirkland JL, Stancel GM, Gardner RM. Effect of a diabetic state on myometrial ultrastructure and isolated uterine contractions in the rat. Proc Soc Exp Biol Med. 1985 Dec; 180(3):497-504. PMID: 4080698.
      View in: PubMed
    54. Robison AK, Sirbasku DA, Stancel GM. DDT supports the growth of an estrogen-responsive tumor. Toxicol Lett. 1985 Sep; 27(1-3):109-13. PMID: 4060181.
      View in: PubMed
    55. Mukku VR, Stancel GM. Regulation of epidermal growth factor receptor by estrogen. J Biol Chem. 1985 Aug 15; 260(17):9820-4. PMID: 2991264.
      View in: PubMed
    56. Mukku VR, Stancel GM. Receptors for epidermal growth factor in the rat uterus. Endocrinology. 1985 Jul; 117(1):149-54. PMID: 2988913.
      View in: PubMed
    57. Frederick GT, Kirkland JL, Stancel GM, Gardner RM. Effects of experimentally-induced diabetes on oestradiol-stimulated changes in the ultrastructure of the rat endometrium. Acta Endocrinol (Copenh). 1985 Mar; 108(3):414-20. PMID: 3984666.
      View in: PubMed
    58. Robison AK, Schmidt WA, Stancel GM. Estrogenic activity of DDT: estrogen-receptor profiles and the responses of individual uterine cell types following o,p'-DDT administration. J Toxicol Environ Health. 1985; 16(3-4):493-508. PMID: 4087314.
      View in: PubMed
    59. Robison AK, Mukku VR, Spalding DM, Stancel GM. The estrogenic activity of DDT: the in vitro induction of an estrogen-inducible protein by o,p'-DDT. Toxicol Appl Pharmacol. 1984 Dec; 76(3):537-43. PMID: 6506078.
      View in: PubMed
    60. McDonald D, Stancel GM, Enna SJ. Binding and function of serotonin 2 receptors following chronic administration of imipramine. Neuropharmacology. 1984 Nov; 23(11):1265-9. PMID: 6098843.
      View in: PubMed
    61. Kirkland JL, Mukku VR, Hardy M, Stancel GM. Hormonal control of uterine growth: alterations in luminal epithelial deoxyribonucleic acid synthesis after intraluminal application of estrogen. Endocrinology. 1984 Mar; 114(3):969-73. PMID: 6697970.
      View in: PubMed
    62. Bhansali KG, Hayes BE, Mukku VR, Stancel GM, Clarke DE. Effect of ovariectomy and estrogen treatment on uterine benzylamine oxidase and monoamine oxidase type A. Res Commun Chem Pathol Pharmacol. 1983 Jul; 41(1):37-49. PMID: 6622831.
      View in: PubMed
    63. Mukku VR, Kirkland JL, Hardy M, Stancel GM. Evidence for thyroid hormone receptors in uterine nuclei. Metabolism. 1983 Feb; 32(2):142-5. PMID: 6298566.
      View in: PubMed
    64. Robison AK, Stancel GM. The estrogenic activity of DDT: correlation of estrogenic effect with nuclear level of estrogen receptor. Life Sci. 1982 Nov 29; 31(22):2479-84. PMID: 7154847.
      View in: PubMed
    65. Mukku VR, Kirkland JL, Hardy M, Stancel GM. Hormonal control of uterine growth: temporal relationships between estrogen administration and deoxyribonucleic acid synthesis. Endocrinology. 1982 Aug; 111(2):480-7. PMID: 7094882.
      View in: PubMed
    66. Kendall DA, Stancel GM, Enna SJ. The influence of sex hormones on antidepressant-induced alterations in neurotransmitter receptor binding. J Neurosci. 1982 Mar; 2(3):354-60. PMID: 7062114.
      View in: PubMed
    67. Kendall DA, Slopis J, Duman R, Stancel GM, Enna SJ. The influence of hormones on drug-induced modifications in neurotransmitter receptor binding. Prog Clin Biol Res. 1982; 79:193-207. PMID: 6124004.
      View in: PubMed
    68. Stancel GM, Prescott DM, Liskay RM. Most of the G1 period in hamster cells is eliminated by lengthening the S period. Proc Natl Acad Sci U S A. 1981 Oct; 78(10):6295-8. PMID: 6947230.
      View in: PubMed
    69. Mukku VR, Kirkland JL, Hardy M, Stancel GM. Stimulatory and inhibitory effects of estrogen and antiestrogen on uterine cell division. Endocrinology. 1981 Oct; 109(4):1005-10. PMID: 7285857.
      View in: PubMed
    70. Strada SJ, Epstein PM, Gardner EA, Thompson WJ, Stancel GM. Evidence for convertible forms of soluble uterine cyclic nucleotide phosphodiesterase. Biochim Biophys Acta. 1981 Sep 15; 661(1):12-20. PMID: 6271215.
      View in: PubMed
    71. Kirkland JL, Barrett GN, Stancel GM. Decreased cell division of the uterine luminal epithelium of diabetic rats in response to 17 beta-estradiol. Endocrinology. 1981 Jul; 109(1):316-8. PMID: 7016511.
      View in: PubMed
    72. Kirkland JL, Gardner RM, Mukku VR, Akhtar M, Stancel GM. Hormonal control of uterine growth: the effect of hypothyroidism on estrogen-stimulated cell division. Endocrinology. 1981 Jun; 108(6):2346-51. PMID: 7227309.
      View in: PubMed
    73. Kendall DA, Stancel GM, Enna SJ. Imipramine: effect of ovarian steroids on modifications in serotonin receptor binding. Science. 1981 Mar 13; 211(4487):1183-5. PMID: 6258229.
      View in: PubMed
    74. Stancel GM, Ireland JS, Mukku VR, Robison AK. The estrogenic activity of DDT: in vivo and in vitro induction of a specific estrogen inducible uterine protein by o,p'-DDT. Life Sci. 1980 Sep 22; 27(12):1111-7. PMID: 7421403.
      View in: PubMed
    75. Ireland JS, Mukku VR, Robison AK, Stancel GM. Stimulation of uterine deoxyribonucleic acid synthesis by 1,1,1-trichloro-2-(p-chlorophenyl)-2-(o-chlorophenyl)ethane (o,p'-DDT). Biochem Pharmacol. 1980 Jun 01; 29(11):1469-74. PMID: 7396982.
      View in: PubMed
    76. Kirkland JL, LaPointe L, Justin E, Stancel GM. Effects of estrogen on mitosis in individual cell types of the immature rat uterus. Biol Reprod. 1979 Sep; 21(2):269-72. PMID: 486654.
      View in: PubMed
    77. Epstein PM, Pledger WJ, Gardner EA, Stancel GM, Thompson WJ, Strada SJ. Activation of mammalian cyclic AMP phosphodiesterases by trypsin. Biochim Biophys Acta. 1978 Dec 08; 527(2):442-55. PMID: 215213.
      View in: PubMed
    78. Gardner RM, Kirkland JL, Stancel GM. Selective blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine. Endocrinology. 1978 Nov; 103(5):1583-9. PMID: 748005.
      View in: PubMed
    79. Gardner RM, Kirkland JL, Ireland JS, Stancel GM. Regulation of the uterine response to estrogen by thyroid hormone. Endocrinology. 1978 Oct; 103(4):1164-72. PMID: 744139.
      View in: PubMed
    80. Gardner EA, Thompson WJ, Strada SJ, Stancel GM. Characterization of soluble uterine cyclic nucleotide phosphodiesterase. Biochemistry. 1978 Jul 25; 17(15):2995-3000. PMID: 212098.
      View in: PubMed
    81. Kirkland JL, Gardner RM, Ireland JS, Stancel GM. The effect of hypophysectomy on the uterine response to estradiol. Endocrinology. 1977 Aug; 101(2):403-10. PMID: 885113.
      View in: PubMed
    82. Weil PA, Sidikaro J, Stancel GM, Blatti SP. Hormonal control of transcription in the rat uterus. Stimulation of deoxyribonucleic acid-dependent RNA polymerase III by estradiol. J Biol Chem. 1977 Feb 10; 252(3):1092-8. PMID: 838697.
      View in: PubMed
    83. Juliano JV, Stancel GM. Estrogen receptors in the rat uterus. Retention of hormone-receptor complexes. Biochemistry. 1976 Feb 24; 15(4):916-20. PMID: 174722.
      View in: PubMed
    84. Gannon F, Katzenellenbogen B, Stancel G, Gorski J. Estrogen-receptor movement to the nucleus: discussion of a cytoplasmic-exclusion hypothesis. Symp Soc Dev Biol. 1976; (34):137-49. PMID: 1020010.
      View in: PubMed
    85. Stancel GM, Thompson WJ, Strada SJ. Cyclic nucleotide phosphodiesterases in uterine development. Mol Cell Endocrinol. 1975 Oct; 3(4):283-95. PMID: 172392.
      View in: PubMed
    86. Stancel GM, Gorski J. Analysis of cytoplasmic and nuclear estrogen-receptor proteins by sucrose density gradient centrifugation. Methods Enzymol. 1975; 36:166-76. PMID: 162977.
      View in: PubMed
    87. Pledger WJ, Stancel GM, Thompson WJ, Strada SJ. Separation of multiple forms of cyclic nucleotide phosphodiesterases from rat brain by isoelectrofocusing. Biochim Biophys Acta. 1974 Nov 25; 370(1):242-8. PMID: 4371847.
      View in: PubMed
    88. Stancel GM, Leung KM, Gorski J. Estrogen receptors in the rat uterus. Relationship between cytoplasmic and nuclear forms of the estrogen binding protein. Biochemistry. 1973 May 22; 12(11):2137-41. PMID: 4350311.
      View in: PubMed
    89. Stancel GM, Leung KM, Gorski J. Estrogen receptors in the rat uterus. Multiple forms produced by concentration-dependent aggregation. Biochemistry. 1973 May 22; 12(11):2130-6. PMID: 4122353.
      View in: PubMed
    90. Gorski J, Williams D, Giannopoulos G, Stancel G. The continuing evolution of an estrogen-receptor model. Adv Exp Med Biol. 1973; 36(0):1-14. PMID: 4369275.
      View in: PubMed
    91. Stancel GM, Deal WC. Reversible dissociation of yeast glyceraldehyde 3-phosphate dehydrogenase by adenosine triphosphate. Biochemistry. 1969 Oct; 8(10):4005-11. PMID: 4310323.
      View in: PubMed
    92. Stancel GM, Deal WC. Metabolic control and structure of glycolytic enzymes. V. Dissociation of yeast glyceraldehyde-3-phosphate dehydrogenase into subunits by ATP. Biochem Biophys Res Commun. 1968 May 10; 31(3):398-403. PMID: 5653652.
      View in: PubMed
    93. Effect of propylthiouracil treatment on the uterine response to estradiol. Federation Proceedings. 36.
    94. Effects of ovarian steroids on receptor levels for neurotransmitters in the CNS. Pharmacologist. 22:335.
    95. Separation of uterine cyclic AMP and cyclic GMP phosphodiesterase activity by trypsin treatment. Federation Proceedings. 38.
    96. Erratum. Biochemical Pharmacology. 57:1447.
    97. Regulation of estrogen stimulated cell division in the rat uterus by thyroid hormone. Federation Proceedings. 37.
    98. The antiestrogenic activity of o,p'-DDT. Pharmacologist. 22.
    99. Characterization of uterine RNA polymerases from unstimulated and estrogen treated rats. Federation Proceedings. 38.
    100. The uterotrophic actions of the antiestrogen nafoxidine. Pharmacologist. 22.
    101. Sex hormones and the neurochemical response to antidepressant drugs. Federation Proceedings. 40:71.
    102. The effect of antiestrogen pretreatment on the uterine response to estradiol. Pharmacologist. 19.
    103. Temporal relationships between estrogen administration and uterine DNA synthesis. Federation Proceedings. 41.
    104. Antiestrogens. Trends in Pharmacological Sciences. 2:98-101.
    105. The effect of hypophysectomy on the uterine response to estradiol. Pharmacologist. 18.
    106. Characterization of uterine phosphodiesterase and effects of estrogen on enzyme activity. Federation Proceedings. 35.
    107. Estradiol (e2) regulates vascular endothelial growth factor (vegf) itlrna in the uterus. FASEB Journal. 10.
    STANCEL's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description